Abstract:Rationale and Objectives Central neurocytomas (CNCs) are rare benign tumors typically located in the lateral ventricle of the central nervous system. The authors report five patients with CNCs and review 16 previously published studies that included 52 patients with CNCs to explore the magnetic resonance spectroscopic features of CNCs. Materials and Methods Five patients with CNCs were retrospectively reviewed. They were examined using point-resolved spectroscopic series with short and/or long echo times. The integrals of choline, creatine, and the 3.55-ppm peak were determined using Magnetic Resonance User Interface software, and the metabolite ratios relative to creatine were obtained. In two cases, T2 relaxation times of choline and the metabolite resonance at 3.55 ppm were calculated using data points acquired with different echo times and an exponential decay model. Results Consistent with previously published studies, all five patients showed highly increased choline and reduced N-acetylaspartate and creatine. Four patients in the present study and 35 in published data demonstrated prominent peaks at 3.55 ppm, which were assigned to glycine because of its relaxation pattern and long T2 relaxation time. In addition, increased in vivo glutamate and glutamine was also confirmed in three patients examined with short echo times. Alanine and lactate peaks were observed in three and two patients, respectively. Conclusions The present study shows that the 3.55-ppm peak characteristic of CNC should be assigned to glycine according to its T2 relaxation time. Besides increased glycine and choline, the presence of glutamate or glutamine, which appears on series with short echo times, may further confirm the diagnosis of CNC. Central neurocytomas (CNCs) are rare benign tumors typically located in the lateral ventricle of the central nervous system. The authors report five patients with CNCs and review 16 previously published studies that included 52 patients with CNCs to explore the magnetic resonance spectroscopic features of CNCs. Five patients with CNCs were retrospectively reviewed. They were examined using point-resolved spectroscopic series with short and/or long echo times. The integrals of choline, creatine, and the 3.55-ppm peak were determined using Magnetic Resonance User Interface software, and the metabolite ratios relative to creatine were obtained. In two cases, T2 relaxation times of choline and the metabolite resonance at 3.55 ppm were calculated using data points acquired with different echo times and an exponential decay model. Consistent with previously published studies, all five patients showed highly increased choline and reduced N-acetylaspartate and creatine. Four patients in the present study and 35 in published data demonstrated prominent peaks at 3.55 ppm, which were assigned to glycine because of its relaxation pattern and long T2 relaxation time. In addition, increased in vivo glutamate and glutamine was also confirmed in three patients examined with short echo times. Alanine and lactate peaks were observed in three and two patients, respectively. The present study shows that the 3.55-ppm peak characteristic of CNC should be assigned to glycine according to its T2 relaxation time. Besides increased glycine and choline, the presence of glutamate or glutamine, which appears on series with short echo times, may further confirm the diagnosis of CNC.

MRS characterization of central neurocytomas using glycine

Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors

Central neurocytoma: typical magnetic resonance spectroscopy findings and atypical ventricular dissemination

Proton MR Spectroscopy of Central Neurocytoma Using Short and Long Echo Time

Significance of MR Spectroscopy in the Classification of Intracranial Astrocytic Tumors

Differential diagnosis in the intracranial diseases: Proton magnetic resonance spectroscopy study

Central Neurocytoma: Radiological and Clinico-Pathological Findings in 18 Patients and One Additional MRS Case

In vivo detection of brain glycine with echo-time-averaged (1)H magnetic resonance spectroscopy at 4.0 T

In Vivo Hydrogen-1 Magnetic Resonance Spectroscopy Study of Human Intracranial Tumors.

In Vitro Brain Tumors: Initial Study Using High Resolution Magic Angle Spinning 1H MR Spectroscopy

Measurement of glycine in gray and white matter in the human brain in vivo by 1H MRS at 7.0 T

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.

Amino acid metabolism in glioma: in vivo MR-spectroscopic detection of alanine as a potential biomarker of poor survival in glioma patients

Elevated glycine detected on in vivo magnetic resonance spectroscopy in a breast cancer patient: case report and literature review

Study of 1H-Magnetic Resonance Spectroscopy in the Peritumoral Edema of Astrocytomas in Brain

Peak Resembling N-acetylaspartate (NAA) on Magnetic Resonance Spectroscopy of Brain Metastases

The value of ~1H-MRS in cerebral glioma

1H-MR spectroscopy in grading of cerebral glioma: A new view point, MRS image quality assessment

Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy

In Vivo MR Spectroscopy Characteristics of Rat C6 Glioma Model and Its Histology Apperance

Utility of 3T single-voxel proton MR spectroscopy for differentiating intracranial meningiomas from intracranial enhanced mass lesions